Wang Y - Search Results

1

Novel agent induction therapy alone or followed by autologous stem cell transplantation in younger patients with multiple myeloma: A single-center retrospective study of 114 cases.

Wang Y, Xu P, Chen Y, Fan Q, Li J, Zhao W, Mi J, Yan H. Wang Y, et al. Mol Clin Oncol. 2016 Jan;4(1):107-113. doi: 10.3892/mco.2015.658. Epub 2015 Oct 16. Mol Clin Oncol. 2016. PMID: 26870367 Free PMC article.

2

[Clinical study of multiple myeloma: a report of 182 cases].

Xu L, Wang Y, Wu W, Yan H, Gao XD, Yu Q, Shen ZX, Mi JQ. Xu L, et al. Among authors: wang y. Zhonghua Yi Xue Za Zhi. 2010 Apr 13;90(14):972-7. Zhonghua Yi Xue Za Zhi. 2010. PMID: 20646647 Chinese.

3

Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.

Xu PP, Wang Y, Shen Y, Wang L, Shen ZX, Zhao WL. Xu PP, et al. Among authors: wang l, wang y. Med Oncol. 2012 Sep;29(3):2176-82. doi: 10.1007/s12032-011-0011-0. Epub 2011 Jun 28. Med Oncol. 2012. PMID: 21710236

4

[Treatment options and prognosis in newly diagnosed multiple myeloma patients].

Wang L, Tang W, Wang Y, Xu L, Zhao WL, Wu W, Chen YB, Shen ZX, Hu J. Wang L, et al. Among authors: wang y. Zhonghua Xue Ye Xue Za Zhi. 2011 May;32(5):308-12. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 21729598 Chinese.

5

Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance.

Yu W, Chen Y, Xiang R, Xu W, Wang Y, Tong J, Zhang N, Wu Y, Yan H. Yu W, et al. Among authors: wang y. Leuk Lymphoma. 2017 Feb;58(2):428-437. doi: 10.1080/10428194.2016.1190968. Epub 2016 Jul 20. Leuk Lymphoma. 2017. PMID: 27439454

6

Autophagy and Myeloma.

Zheng Z, Wang L, Cheng S, Wang Y, Zhao W. Zheng Z, et al. Among authors: wang l, wang y. Adv Exp Med Biol. 2020;1207:625-631. doi: 10.1007/978-981-15-4272-5_45. Adv Exp Med Biol. 2020. PMID: 32671780 Review.

7

Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and Lenalidomide.

Cheng L, Song Q, Liu M, Wang Y, Yi H, Qian Y, Xu P, Cheng S, Wang C, Wang L, Zhao W. Cheng L, et al. Among authors: wang l, wang y, wang c. Front Immunol. 2021 Jul 12;12:702593. doi: 10.3389/fimmu.2021.702593. eCollection 2021. Front Immunol. 2021. PMID: 34322131 Free PMC article.

8

[Clinical features and prognostic analysis of mantle cell lymphoma].

Bao WY, Wang Y, Hu XM, Li JM, Shen ZX, Zhao WL. Bao WY, et al. Among authors: wang y. Zhonghua Xue Ye Xue Za Zhi. 2012 Oct;33(10):814-8. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 23384900 Chinese.

9

Targeting poly (ADP-ribose) polymerase partially contributes to bufalin-induced cell death in multiple myeloma cells.

Huang H, Cao Y, Wei W, Liu W, Lu SY, Chen YB, Wang Y, Yan H, Wu YL. Huang H, et al. Among authors: wang y. PLoS One. 2013 Jun 7;8(6):e66130. doi: 10.1371/journal.pone.0066130. Print 2013. PLoS One. 2013. PMID: 23762475 Free PMC article.

10

MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway.

Xiang RF, Wang Y, Zhang N, Xu WB, Cao Y, Tong J, Li JM, Wu YL, Yan H. Xiang RF, et al. Among authors: wang y. Cell Death Dis. 2017 May 11;8(5):e2776. doi: 10.1038/cddis.2017.188. Cell Death Dis. 2017. PMID: 28492559 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299,493 results

Search Page

Filters